- OmniAb reported **Q3 2025 revenue of $2.2 million**, a decrease from $4.2 million in Q3 2024, and a **net loss of $16.5 million**, or **$0.14 per share**.  **[1846253_0001628280-25-048850_a2025q3ex991.htm:0]**  For the nine months ended September 30, 2025, revenue was **$10.3 million** with a **net loss of $50.6 million**, or **$0.46 per share**.  **[1846253_0001628280-25-048850_a2025q3ex991.htm:1]** 
- The company updated its **2025 financial guidance**, now expecting revenue in the range of **$18 million to $22 million** and operating expenses between **$82 million and $86 million**.  **[1846253_0001628280-25-048850_a2025q3ex991.htm:1]** 
- As of September 30, 2025, OmniAb held **$59.5 million** in cash, cash equivalents, and short-term investments, following **$28 million in net proceeds** from a private placement completed in August.  **[1846253_0001628280-25-048850_a2025q3ex991.htm:1]** 
- OmniAb expanded its active partners to **104** and active programs to **399**, and plans to launch its new **OmniUltra™ technology** in December 2025.  **[1846253_0001628280-25-048850_a2025q3ex991.htm:2]**

OmniAb (OABIW)